Zoetis Inc (ZTS)
163.15
-2.75
(-1.66%)
USD |
NYSE |
Jan 07, 14:24
Zoetis Research and Development Expense (Quarterly): 167.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 875.90M |
| Alnylam Pharmaceuticals Inc | 270.93M |
| Biomarin Pharmaceutical Inc | 184.90M |
| Corcept Therapeutics Inc | 59.34M |
| Plus Therapeutics Inc | 2.858M |